Clinical Trials

Clinical Trial Detail

Return to search results.

Modulation of Intensive Melphalan (L-PAM) by Buthionine Sulfoximine (BSO) with Autologous Stem Cell Support for Resistant/Recurrent High-Risk Neuroblastoma (IND #69,112)

Research Study Number       NANT 99-02
Principal Investigator       Julie Park, MD
Phase       I

Look up trial at NIH

Research Study Number       NANT 99-02
Contact       Seattle Children's Outpatient Attending MD
Telephone       (206) 987-2106
Other URLs that may be
of interest include

Bone Marrow and Hematopoietic Stem Cell Transplant (BMT and HSCT); Neuroblastoma; Solid Tumors

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:

  • Talk to your health care providers first before making decisions about your health care.
  • Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.

Subscribe to an RSS feed of all trials